what is glp 1 medicine GLP-1 GLP-1 Type 1 Adjunct Therapy:

R.SuoP.ChenJ

Novo Nordisk sues rival drugmaker Eli Lilly over GLP-1 ads Novo Nordisk is suing Eli Lilly over its GLP-1 ads, accusing the rival drugmaker of false advertising for claiming Lillys Mounjaro and Zepbound outperform Novos Ozempic and Wegovy

Request sauces on the side

Funayama T, Nozu T, Ishioh M, Igarashi S, Sumi C, Saito T, Toki Y, Hatayama M, Yamamoto M, Shindo M, Tanabe H, Okumura T

These agents are also well-known to induce weight loss, making them suitable for patients with obesity or those seeking weight reduction

Some employers are exploring options such as HRA accounts to subsidize the cost of the medication while limiting their financial exposure